NICE recommends semaglutide should be made available in specialist NHS services
The UK’s regulatory body, NICE, has recommended the use of semaglutide (also called Wegovy or Ozempic) alongside a reduced-calorie diet...
top of page
Browse by category
Search
STEP 5: Semaglutide improves short- and longer-term control of eating with weight loss
Adults with overweight or obesity who took semaglutide demonstrated short- and longer-term improvements in controlling their eating...
STEP TEENS: semaglutide shows weight loss in adolescents
Semaglutide is effective in helping adolescents lose weight and improves cardiac health, according to a study, ‘Once-Weekly Semaglutide...
Top 10 most read articles on Bariatric News - September 2022
It has been another busy month reporting the latest bariatric and metabolic, and obesity-related disease news. We hope we have brought...
Analysis of STEP clinical trials shows semaglutide more than halves risk of T2DM
The risk of type 2 diabetes mellitus (T2DM) is more than halved by weekly injections of new obesity drug semaglutide, according to...
Journal Watch 21/09/22
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
STEP 8: Greater weight loss for once-weekly semaglutide vs daily liraglutide
Once-weekly subcutaneous semaglutide (2.4mg) is more effective on weight loss in conjunction with counselling and physical activity vs...
Endoscopic sleeve gastroplasty plus semaglutide increases weight loss
Combining minimally invasive endoscopic sleeve gastroplasty (ESG) with semaglutide can provide additional significant weight loss for...
Browse by tag
bottom of page